ArticleJournal of cachexia, sarcopenia and muscle2026
Validity of Bioelectrical Impedance Analysis for the Assessment of Body Composition in Patients With Systemic Sclerosis.
Article in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundSystemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy and progressive fibrosis. Reduced muscle mass is common and contributes to myopenia, sarcopenia and adverse clinical outcomes. Dual-energy X-ray absorptiometry (DXA) is the most widely used method in clinical research and is recommended by international guidelines as the reference standard for muscle mass evaluation in sarcopenia. However, its accessibility in routine clinical practice is limited. Bioelectrical impedance analysis (BIA) is a validated method for assessing body composition due to its affordability, ease of use and non-invasive nature. Nevertheless, variability across devices and assessment protocols may influence measurement accuracy, underscoring the need for validation in specific clinical populations. This study compared body composition measured by BIA and DXA and evaluated the diagnostic accuracy of BIA for detecting myopenia in SSc.
methodsIn this cross-sectional study, patients with SSc underwent body composition assessment by BIA (InBody 370 s) and DXA (Lunar Prodigy Primo). Fat mass (FM), fat mass index (FMI), fat-free mass (FFM), fat-free mass index (FFMI), appendicular skeletal muscle mass (ASM), appendicular skeletal muscle mass index (ASMI) and ASM adjusted by body mass index (ASM/BMI) were assessed. Myopenia was defined according to established muscle mass criteria. Agreement was evaluated using Bland-Altman analysis and Lin's concordance correlation coefficient (CCC). Diagnostic performance was assessed using receiver operating characteristic (ROC) curves.
resultsOne hundred patients with SSc were included (91% women; mean age 60.1 ± 11.5 years; median disease duration 11.5 [5.0-20.3] years). Disease subtypes comprised 23% diffuse cutaneous, 61% limited cutaneous and 16% sine scleroderma. BIA demonstrated excellent agreement with DXA (CCC > 0.900) for ASM/BMI [Δ = 0.032; 95% CI 0.019-0.045], FM (Δ = -0.401; 95% CI -0.804 to 0.003), FMI (Δ = -0.190; 95% CI -0.366 to -0.015) and FFM (Δ = -0.010; 95% CI -0.415 to 0.395). Good concordance (CCC 0.750-0.900) was observed for ASM (Δ = 0.803; 95% CI 0.518-1.088). In women, ROC analysis showed high discriminative ability, with AUCs of 0.956 (95% CI 0.908-1.000) for ASM, 0.878 (95% CI 0.763-0.993) for ASMI and 0.969 (95% CI 0.935-1.000) for ASM/BMI. The optimal ASM/BMI cut-off (0.506) yielded 100% sensitivity and 90.1% specificity (PPV 55.6%, NPV 100%).
conclusionBIA showed high agreement with DXA and strong diagnostic accuracy for detecting myopenia in SSc, particularly in women. These findings support BIA as an accessible tool for body composition assessment in SSc when standardized conditions and validated sex-specific cut-offs are applied.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.